ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000236.1|Kinamycin_3 # 1344 # 2255 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0000236.1|Kinamycin_3 	1344	2255	+	Loose	1750	28.8758	amrB	36.59	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGCTGACTCCACACTCGAAGTGCGCTTCGAACGCGCGCTGGCCAGCCTGCGCGGACTGGCCGTGGGAGACGCCCTGGGCTCCCAGTTCTTCGTCCCCGTCAACTATCCCCTGCTCAAGCGCCGCGAGCTGCCCGCCGGCCGCTGGCAGTGGACCGACGACACCGAGATGGCCTGCTCGGTCCTCGCGGTCCTGGCCGCGAGCGGCCGGATCGACCAGGACCTCCTGGCCCGCTCCTTCGCCGAGCACCACGACTTCGACCGGGGGTACGGCCCGGCCGTGAACCGGATGCTGCGGCTGATCCGGGAGGGCGGGGACTGGCGCGAGCTGGCCGCCGCGCTCTTCAACGGCCAGGGCTCCTGGGGCAACGGCTCCGCGATGCGGATCGCGCCGCTGGGCGCCTGGTACGCGGATGACCCGGAGCAGGCCACGCACCAGGCCGAGATCTCTTCGTACACCACCCACCAGCACCGGGAGGCCGTGGTGGGCGCGATGGCGGTGGCCGCGGCCGCGGCCCTCGTGGCCGCTCCGACGGGCCCGCCGACCCCGGCGGACCTCCTTGACGGCGTGGTCGCGCTGGTGCCGCGCAGCGCCGTCGGCGCGGGGCTGCGGCGGGCGCGGGACATGCTCGACTACGGGGACGCGACCACGGTCGCGGCGGTCCTCGGCTGCGGCCGGCGCACCAGCGCGCACGACACCGTGCCGTTCGCGCTCTGGTCGGCGGCGCGCGGGCTCGGGGCGTACGAGAAGGCGTTCTGGACGACCGCGCAGGCCGGTGGCGACATCGACACGACCTGCGCGATCGTCGGCGGTGTGGTCGCCGCCGCCGCGGCCGGGGCGCCCCCGGCCCAGTGGCTGGAGCGGACCGAGGAGCTGCCCGACTGGGTGCCGGCGACCGCGCCGCGCTGA	MTADSTLEVRFERALASLRGLAVGDALGSQFFVPVNYPLLKRRELPAGRWQWTDDTEMACSVLAVLAASGRIDQDLLARSFAEHHDFDRGYGPAVNRMLRLIREGGDWRELAAALFNGQGSWGNGSAMRIAPLGAWYADDPEQATHQAEISSYTTHQHREAVVGAMAVAAAAALVAAPTGPPTPADLLDGVVALVPRSAVGAGLRRARDMLDYGDATTVAAVLGCGRRTSAHDTVPFALWSAARGLGAYEKAFWTTAQAGGDIDTTCAIVGGVVAAAAAGAPPAQWLERTEELPDWVPATAPR	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	29.05	gnl|BL_ORD_ID|428|hsp_num:0	476			2898	3021	
BGC0000236.1|Kinamycin_4 # 2259 # 3755 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000236.1|Kinamycin_4 	2259	3755	-	Loose	1000	255.758	efpA	40.99	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGACCGCCCCGGCATAGCCCTCGCCGTCATCGCGATGTGCCAGCTGATGGTGGTGCTCGACGCGACGATCGTGAACATCGCGCTCCCCCACATCCAGACCTCCCTCGGCTTCTCCACCAGCGATCTGACCTGGGTCATCAACGCGTACGCGCTGACCTTCGGCGGACTGCTGCTGCTCGGCGGGCGGGCCGGCGACCTGCTCGGCCGGCGCCGGATGTTCATCACCGGCATCCTGCTCTTCACCCTCGCCTCGCTGCTCGGCGGCTTCGCCCAGGAGCCCTGGCAGCTGCTCGCCGCGCGCGCCCTGCAGGGCGTCGGCGGCGCCATCGCCTCCCCCACCTCGCTCGCCCTGATCGCGACGACGTTCCCCGAAGGGCCCGAGCGCAACCGGGCGTTCGGCGTCTTCTCGGCGGTCTCGGCGGGCGGCGGCGCCATCGGCCTGATCGCGGGCGGCATGCTCACGGACTGGCTCAACTGGCGCTGGGTGCTCTTCGTGAACGTCCCGATCGGCCTGGTCATCGCCGCGCTCGCGCCCCGCTGCATCAGGGAGTCGCAGCGCCACTCCGGCTCCTTCGACCTGGCCGGCGCGTTCACCTCCACGGGTGGCATGGCCGCGCTGGTCTACGGGTTCATCCGGTCCGCGAACGACGGCTGGCGCGACGGCGGAACGCTGGCCTCCTTCGGCGCCGCCGTGGTCCTGCTGCTCGCCTTCGTCGCGGTGGAGCGCCGCTCGGCGCAGCCCATCACCCCGCTGCGGATGTTCGCCGACCGCAACCGCTCCGGTACGTACGTGATCATGCTGAGCCTCGCCGCGGCCATGTTCGGCATGTTCTTCTTCATCGTGCTCTTCGTGCAGAACGTGCTGCACTACAGCCCGGTCAAGGCGGGCGTCGCGTTCTTCCCGTCGACCCTGGCCATCGTCCTCGCGGCGGGCCTCGCGACGACCTTCCTGCCCCGCATCGGCCCCAAGCCGATCGTGGTCACCGGCTCGCTGATCACCGGGGGCGCGATGGCGTGGCTGACCCTGATCAAGCCCGACAGCACCTACGCGGGCGGGATCATCGGCCCGCTGCTGCTCTTCGGCTTCGGCATGGGCCTCAACTTCGTCACCCTCACCCTGACCGCGGTCTCCGGCATCGCCGAGCACGAGTCGGGCGCCGCGTCCGGCCTGCTCAACACCACCCAGCAGGTCGGCGGCGCGCTCGGCCTCTCCATCCTGACCACGGTCTTCGGCACCGCGAGCCGCGACGAGGGCAAGACCCAGGTCAAGGACTTCCTCGCGCACGGCTCACCCGAGCAGAAGGCGGCCTTCGCCAAGTCGCGTCAGCTGCCCGCCCCGTGGAGCGACGAGGTCCTCGCCCATGGCATCGGCACGGCCTTCATCGCCGCCGTGGCCCTGGTCGCGGTCGCGGCCGTGGTCGCCCTCTTCGTCGTCCAGGTCCGCAAGAGCGACCTCGAAGCCCTCAGTGGCCGCACCGGGGCCCCGGCCGGGTAA	MDRPGIALAVIAMCQLMVVLDATIVNIALPHIQTSLGFSTSDLTWVINAYALTFGGLLLLGGRAGDLLGRRRMFITGILLFTLASLLGGFAQEPWQLLAARALQGVGGAIASPTSLALIATTFPEGPERNRAFGVFSAVSAGGGAIGLIAGGMLTDWLNWRWVLFVNVPIGLVIAALAPRCIRESQRHSGSFDLAGAFTSTGGMAALVYGFIRSANDGWRDGGTLASFGAAVVLLLAFVAVERRSAQPITPLRMFADRNRSGTYVIMLSLAAAMFGMFFFIVLFVQNVLHYSPVKAGVAFFPSTLAIVLAAGLATTFLPRIGPKPIVVTGSLITGGAMAWLTLIKPDSTYAGGIIGPLLLFGFGMGLNFVTLTLTAVSGIAEHESGAASGLLNTTQQVGGALGLSILTTVFGTASRDEGKTQVKDFLAHGSPEQKAAFAKSRQLPAPWSDEVLAHGIGTAFIAAVALVAVAAVVALFVVQVRKSDLEALSGRTGAPAG	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	93.96	gnl|BL_ORD_ID|2188|hsp_num:0	2427			159	1371	rifampin; isoniazid
BGC0000236.1|Kinamycin_5 # 4059 # 5483 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000236.1|Kinamycin_5 	4059	5483	-	Loose	1000	26.5646	almE	46.67	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCGATCGGGGCGGAGTCTCCCCGTAAAGCGCGGGGAAAGTCCAGGGATTTCAGAAGTCGAAGCCGAGCTGGCCCCCGCTTTCCAGTGCGGCCGCCGCCGCGGAGACGCGGACCTTCTTCAAGTGCCGCCAGCGGGGCAGCGCGTCGAGATACGACCAGGACAGCCGGTGGTACGGGGTGGGACCCCACTCCACCAGGGCCGTCTTGTGCGTGGGCGAGGGGTAACCGGCGTTGTCGGCGAAGCCGAACGCCGCGCACTCCCCCGCCGCTCCCCCCAGTTCGGCCATCATCGCGTCCCGGCGCACCTTGGCGATCACCGAGGCGGCCGCGACCGCGACGCAGGACTGGTCCCCCTTGATGACGGTACGGACCCACCACGGGTCGCCGAGATAGTCGTGCTTTCCGTCGAGAATCACCGCCTCCGGTTTCACCGGAAGCCCGTCCAGGGCGCGTACGGCGGCGAGACGGAGCGCGGCGGTCATTCCGAGCTCGTCGATCTCCTGGGGCGAGGAGTGCCCGAGTGCGTACGCGGTCACCCAGGACTCCAGCTCCCCGGCCAGTTCGAGGCGGCGCTTGGGGCTGATCAGCTTGGAGTCGGTCAGGCCCTCGGGCGGTCGGCGCAGCCCCGTGATGGCGGCGCACACCGTGACGGGACCGGCCCACGCCCCGCGTCCGACTTCGTCGACACCGGCGATGATCTTGTAGCCGGTGGTGGCGCGGATCGAGCGCTCGACGGTGTGGGTGGGTGGTTCGTACGGCATGGCGCCAGCAAGGTTACGCCGCCGCGGCCGCCGATGACACCCCGGCCCGCCCGCCCCGCGCGATCGGGCCGGTCAGCGCGTTACGGGCCGCAGCAGCGGCACCAGCACCCGGTCGACCATCTCGGCGACCGCCTCGTCGGGCCATTCGCTTCCGCGCACTTTCGCGCGGAACATCATCAGTCCCGGAATCACATCGAAGATCACCTCGGCCGTGGCGTCGGGCCGTACGTCGCCCCGCGCGATTCCCTGCCGTATCGCCTGTGCGAAAAGCCGCTGAGCGGGCGCGACCATGCGTTGCAGCACCATTCCGTGGAATCGCTCGGCGCTGGCCGCGTCGCATTCGTAAAGCACCGAGCGGAGCGCGAATCCCGAGCGGGAGTACATCGCGTCCCGCAGCCGCAGACAGAGCCGGTAGAGGTCCTCGCGCACCGATCCATGGTCGTCGGCGTGGTCCAGGTCCGGCAGCCCGGACCGCAGCGCGTCGGCCACCAGCTCCTCCTTGGACGACCAGCGCCGGTACACGGCGGCCTTCCCGGTCTGCGCGCGGGCCGCCACGCCCTCCATCGTCAGGGCGTTCCAGCCGACCGTGCTCAGCTGCTCCAGGGTCGCGTCCAGGATCGCCCGCTCCAGGACGGGCCCCCGGCGGCGCGGCGAGACGGGTGA	MRSGRSLPVKRGESPGISEVEAELAPAFQCGRRRGDADLLQVPPAGQRVEIRPGQPVVRGGTPLHQGRLVRGRGVTGVVGEAERRALPRRSPQFGHHRVPAHLGDHRGGRDRDAGLVPLDDGTDPPRVAEIVVLSVENHRLRFHRKPVQGAYGGETERGGHSELVDLLGRGVPECVRGHPGLQLPGQFEAALGADQLGVGQALGRSAQPRDGGAHRDGTGPRPASDFVDTGDDLVAGGGADRALDGVGGWFVRHGASKVTPPRPPMTPRPARPARSGRSARYGPQQRHQHPVDHLGDRLVGPFASAHFRAEHHQSRNHIEDHLGRGVGPYVAPRDSLPYRLCEKPLSGRDHALQHHSVESLGAGRVAFVKHRAERESRAGVHRVPQPQTEPVEVLAHRSMVVGVVQVRQPGPQRVGHQLLLGRPAPVHGGLPGLRAGRHALHRQGVPADRAQLLQGRVQDRPLQDGPPAARRDG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	85.25	gnl|BL_ORD_ID|4935|hsp_num:0	5928			1347	1437	colistin A; colistin B
BGC0000236.1|Kinamycin_6 # 5829 # 6146 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.758	BGC0000236.1|Kinamycin_6 	5829	6146	+	Loose	500	24.2534	FONA-6	27.78	3004793	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FONA beta-lactamase	GTGGACCTGCTGCTCGACACCGGCCGCGCGCCGGGCGACATCCTGGTCCTCACCACCGGTGAGCCGCACCCGTGGGCGGCGCACGAGCTGTCCTTCGGCGAGGCGTCGTACTGGGCCCAGCACGACGCGGGCGACGACGTGTTCTACGCGTCCGCCGCCTCGGTCGAGCGGGCCTCGGCCCGGCCCGTGGTGATCGTCGCGGTCGACGGCGGGGACGCGGCGGTCGCGCTGCCGCTGGCCCGCGAGCGGGCCGGGGCGCTGCTGATCGTCTGCGGTGATCCTGAGCGGATCAACGCGGCGCTCAGCGCGGGCGTCTGA	MDLLLDTGRAPGDILVLTTGEPHPWAAHELSFGEASYWAQHDAGDDVFYASAASVERASARPVVIVAVDGGDAAVALPLARERAGALLIVCGDPERINAALSAGV	MVKNTLRQTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTADNSQILYRADERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL	35.59	gnl|BL_ORD_ID|2327|hsp_num:0	3590			54	216	
BGC0000236.1|Kinamycin_10 # 9654 # 10613 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=CCCCG;rbs_spacer=15bp;gc_cont=0.727	BGC0000236.1|Kinamycin_10 	9654	10613	+	Loose	720	29.6462	emeA	30.91	3003551	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GTGACCTCGGCCCGCCTGCCCGCCTGCCCGCCTGCCCGCCTGCCCGCCTGCCCGCCTGCTAATGATGAGGCCGTAGTCCGGACGCTGTATTCCGGCGTCAGCCGTGGCACGGAATCGCTCGTTTTCCACGGCCGGGTACCCGTCAGTCAGTACGCCGTCATGCGTGCCCCCTTTCAGGAAGGCGACTTTCCCGGACCCGTCAAGTACGGGTATCTCAATGTCGGCCGGGTGGAGGAGGGGCCGGCGGAGCTCGTGGGCCGGGTCGTGTTCAGTCTGTATCCGCACCAGACCCGTTACCGCGTCGCGGCCGACGCCCTCGCGGTGGTGCCCGACGGCGTGCCGCCGGAGCGTGCCGTGCTGGCCGGGACCGTCGAGACCGCGCTCAACGCGCTGTGGGACGCGCCCCCGCGGATCGGTGACCGGATCGCGGTGGTGGGCGCGGGCATGGTCGGCTCCTGTGTGGCCGCGCTCCTGGCTCGGTTCCCCGGTGTCCGCGTGCAGCTCGTCGACGTCGAACCGGCCCGCCAGGCGGTCGCCGCGCGGCTCGGCGTCGCCTTCGCCCCGCCCGAGCGGGCCACTGACGACTGCGATCTCGTCTTCCACGCCAGCGCCACCGAGGCGGGGCTGAGGCGCTCCCTCGAACTGCTCGCTCCCGAGGGCTGTGTGGTCGATCTGAGCTGGTACGGCGACCGGCCGGTGACGCTGCCGCTGGGGGAGTTCTTCCACTCCCGGCGGCTGTCGCTGCGCGGCAGCCAGGTCGGCGCCATCGCGCCGGAGCGCCGCGCACGCCACACGAGGGCCGATCGGCTCGGCATGGCGCTCGACCTCCTGCGGGACCCGGTCTTCGACGTACTGATCACCGGCGAGTCCGATTTCGACGACCTTCCGCAGGTCATGGCCGAGATCGCCACCGGCGCCCGGCCCGGGCTCTGCCACCGCATCCGCTACGGCCCCGGCTGA	MTSARLPACPPARLPACPPANDEAVVRTLYSGVSRGTESLVFHGRVPVSQYAVMRAPFQEGDFPGPVKYGYLNVGRVEEGPAELVGRVVFSLYPHQTRYRVAADALAVVPDGVPPERAVLAGTVETALNALWDAPPRIGDRIAVVGAGMVGSCVAALLARFPGVRVQLVDVEPARQAVAARLGVAFAPPERATDDCDLVFHASATEAGLRRSLELLAPEGCVVDLSWYGDRPVTLPLGEFFHSRRLSLRGSQVGAIAPERRARHTRADRLGMALDLLRDPVFDVLITGESDFDDLPQVMAEIATGARPGLCHRIRYGPG	MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPIAGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVADMTTISERPKAMGLVSAAISGGFIIGPGVGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVLKEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSIMATINFGFTTSEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIAFTKNNLVVVFSTFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAAGALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM	81.17	gnl|BL_ORD_ID|565|hsp_num:0	618			573	738	acriflavine
BGC0000236.1|Kinamycin_11 # 10660 # 11058 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.677	BGC0000236.1|Kinamycin_11 	10660	11058	+	Loose	500	24.2534	APH(3')-Vc	41.86	3002651	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGTTCAGCGTCACCGTCCGCGATCACCTCATGATCGCCCACAGCTTCAGCGGCGAGGTCTTCGGCCCCGCCCAGCGCCTGCACGGAGCGACATACCTGGTCGACGCGACCTTCCAGCGACCGGAGCTGGACGACGACAACATCGTCATCGACATGGGCCTGGCAGGCAGGGAAGTGCGCGGGATCGTCGCGGCGCTCTCGTACCGCAACCTCGACGAGGACCCCGACTTCGCCGGAACCAACACCACCACCGAATTCCTGGCCAAGGTCATCGCCGACCGCCTCGCCGCCCGGATACACGACGGCGCCCTCGGCCCCGGCGCCCAGGGCCTGACCGGACTCACCGTACGGCTCCATGAATCGCACATCGCGTGGGCCGACTACCACCGCACGCTCTGA	MFSVTVRDHLMIAHSFSGEVFGPAQRLHGATYLVDATFQRPELDDDNIVIDMGLAGREVRGIVAALSYRNLDEDPDFAGTNTTTEFLAKVIADRLAARIHDGALGPGAQGLTGLTVRLHESHIAWADYHRTL	MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLTWLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF	50.00	gnl|BL_ORD_ID|634|hsp_num:0	687			603	729	neomycin; ribostamycin; paromomycin
BGC0000236.1|Kinamycin_12 # 11090 # 11749 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.720	BGC0000236.1|Kinamycin_12 	11090	11749	+	Loose	300	31.187	dfrA6 from Proteus mirabilis	24.74	3004644	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGCTGTCCGCGGCCGTCTCCCTGGACGGCCGGCTCGACGACACCTCGCGCGACCGGCTCGTACTCTCCAACCGGCGCGACCTCGACCGTGTCGACGATGAACGCGCCGCCGCGGACGCCATCCTGGTCGGCGCCACCACCCTGCGCAGGGACAACCCGCGCCTGCTGGTGGCGAGCGCCGATCGGCGGGCCCGGCGCGTCGCCCTCGGCATGCCGGAGCATCCGCTGAAGGTCACGGTCACCGGGTCCGCCGAGGTGAACACGTCGTACGCGTTCTGGCACTGCGGCGGCGAGAAGCTGGTGTTCACGGTGGACGGAGCGCTCCTGCGGGCCCGTCGCACCGTAGGCGACCTCGCCGACGTCGTCAGCACCGGCCCCGCTCTCGACTGGCACCTCCTCCTCGACGAACTCGGGCGACGTGGGGTGGAACGCCTTCTGGTCGAAGGCGGCGGGACGGTGCACACCCAGCTGCTGGCCCAGGACCTGGCCGATGAACTCCACCTCGTCGTCGCCCCGTTGCTGGTGGGCGAAGCCGGTGCGCCGGTGTTCCTGGGCCCGGCGTCGTACCCGGGTGGTCCCGCGGCCCGTATGACGCTGCTCGAAGCACGCCCCGTCGGTGATGTCGTGCTGCTGCGCTACGCCCCGAAACTCCGATCCTGA	MLSAAVSLDGRLDDTSRDRLVLSNRRDLDRVDDERAAADAILVGATTLRRDNPRLLVASADRRARRVALGMPEHPLKVTVTGSAEVNTSYAFWHCGGEKLVFTVDGALLRARRTVGDLADVVSTGPALDWHLLLDELGRRGVERLLVEGGGTVHTQLLAQDLADELHLVVAPLLVGEAGAPVFLGPASYPGGPAARMTLLEARPVGDVVLLRYAPKLRS	MKISLMAAVSENGVIGSGLDIPWHVQGEQLLFKAMTYNQWLLVGRKTFDSMGKLPNRKYAVVTRSKIISNDPDVVYFASVESALAYLNNATAHIFVSGGGEIYKALIDQADVIHLSVIHKHISGDVFFPPVPQGFKQTFEQSFSSNIDYTYQIWAKG	139.49	gnl|BL_ORD_ID|2123|hsp_num:0	3343			66	351	trimethoprim
BGC0000236.1|Kinamycin_13 # 11805 # 12170 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0000236.1|Kinamycin_13 	11805	12170	+	Loose	350	23.0978	vanA	37.04	3000010	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGCTCCTCGGGCGCGTGGCCGGACGGTGTGCGGACGAGACGGGGGCGAGTGTGGACGACGCGGTGGAACTGGCGGAGATGATCGGCCAGTTGCGGAGCGAGCTGAGCCGGGCCATGGCGGACGGGGCCGCGGGCGGCGGGCTGCGGTTCCAGGCGGAGAAGCTGGAGCTCGAACTCACCGTGGGCGTGGAGCGCAGCCGGGAGCCGGGTGCGAAGGTGCGGTTCTGGGTGCTCGACGTCCACGGCTCCGCCCGCTCCGCGCGGACCGCCACGCAGCGGATCAAGCTCACCCTGCAACCGGTGCTCGGCGACGCACCCGACAGCCCCGCGCTGATCTCGGGCGCGGAGCTGCCCGATGAGAGCTGA	MLLGRVAGRCADETGASVDDAVELAEMIGQLRSELSRAMADGAAGGGLRFQAEKLELELTVGVERSREPGAKVRFWVLDVHGSARSARTATQRIKLTLQPVLGDAPDSPALISGAELPDES	MNRIKVAILFGGCSEEHDVSVKSAIEIAANINKEKYEPLYIGITKSGVWKMCEKPCAEWENDNCYSAVLSPDKKMHGLLVKKNHEYEINHVDVAFSALHGKSGEDGSIQGLFELSGIPFVGCDIQSSAICMDKSLTYIVAKNAGIATPAFWVINKDDRPVAATFTYPVFVKPARSGSSFGVKKVNSADELDYAIESARQYDSKILIEQAVSGCEVGCAVLGNSAALVVGEVDQIRLQYGIFRIHQEVEPEKGSENAVITVPADLSAEERGRIQETAKKIYKALGCRGLARVDMFLQDNGRIVLNEVNTLPGFTSYSRYPRMMAAAGIALPELIDRLIVLALKG	35.28	gnl|BL_ORD_ID|1830|hsp_num:0	1981			30	111	vancomycin; teicoplanin
BGC0000236.1|Kinamycin_14 # 12252 # 12713 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000236.1|Kinamycin_14 	12252	12713	-	Loose	500	25.409	NDM-29	24.39	3005131	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGATGCGGCTGCCGGCCCACACCGCCGCGCCCGACATGCCCGCCCACGGCGAGGCCGCCGGGTCGGGGTCGGTTCCGGCCGGTGCCACGGTCATCTCCAGCGTGCCGGTCCGCAGATTGGAGAGCGCCGCCACCGTGCCGTCCGCCTGGTGCAGTTCGCGGAAGTACGCGCCGTCGGACCGGCGTCGGCGTTTCCACAGCGGAAACCCGGCGGCGTGCACCCCGATCACCCCGTGCCGGTCGTCGGCGATGCGCGCGAAGCGGGCGGGTGCGGTGACCACGGGGGCGGCCGCAGGTGCCCCGACGCTCAGCACGGCGAGGTCGCTGCCCGCATCCGCCCAGGTCACCATGGCCGGAGCCGACCACTCCGCGGGCTGGTCGGCGTCGCACCGTACGAGCGTGCGGGTCGCGTCGGCGACCACATGGGCGGCGGTGAGGACCGTCGTGGTGGAGATCCGGTAG	MMRLPAHTAAPDMPAHGEAAGSGSVPAGATVISSVPVRRLESAATVPSAWCSSRKYAPSDRRRRFHSGNPAACTPITPCRSSAMRAKRAGAVTTGAAAGAPTLSTARSLPASAQVTMAGADHSAGWSASHRTSVRVASATTWAAVRTVVVEIR	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMNALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	56.67	gnl|BL_ORD_ID|2838|hsp_num:0	3857			180	498	
BGC0000236.1|Kinamycin_16 # 13170 # 13550 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000236.1|Kinamycin_16 	13170	13550	-	Loose	2110	23.0978	MexF	26.87	3000804	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGAGGCTGCCGTCCCGGTCGAGTTCGCGCAGCAGGGCCGCGGCCTCGGTGGGGCGCAGCCCCTCGGAGAGCGGCACCTCGGCGGCGAAGCGGCGCAGTTCGGGCGCGAGACGCACCGGCACCTGGCTGGTGACGAGCAGACGTGGGGTGGTGCGGGCCCGGAACAGCCAGTCCAGGAAGAGGGCCAGCTCCTCGTCCTCGATGCCGCCGTCGTCGCCGAGCAGTTCCTCCAAGTTGTCCATGAGGATGACGATCAGCCGCCCGCCCATGGCGTCGAAGAGTGCGGCGAGGCGGTCCTGCGCGCTGCCGCCGCCCGCCCAGACCCCGCGCAGCCGCTCCTCGTGCTCGGGGCCGAGCAGCCGGACGCAGTCGAAGTAG	MPRLPSRSSSRSRAAASVGRSPSESGTSAAKRRSSGARRTGTWLVTSRRGVVRARNSQSRKRASSSSSMPPSSPSSSSKLSMRMTISRPPMASKSAARRSCALPPPAQTPRSRSSCSGPSSRTQSK	MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKLPEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLFGLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQGRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGSNAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTVNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVIKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAALNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGAPAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSGMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA	11.86	gnl|BL_ORD_ID|2353|hsp_num:0	1300			513	714	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000236.1|Kinamycin_18 # 15125 # 15643 # -1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000236.1|Kinamycin_18 	15125	15643	-	Loose	375	35.4242	nalD	36.67	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGAACGCGGCCAGGGAGCTCTTCGCGGAACGCGGCGCCAACGTGTCCATGGACGAGGTGGCCCGCCGCGCCGAGGTCGGCGTGGGGACGCTCTACCGCCACTTCCCCACCAAGGAAGCCATGGTCGTCGCGGCCTCCCAGCAGCGCTTCGGCGAGATCCTCACGTACTACCGCACGGTCTGCCGGGAGTCGGCCGAGCCGCTGGAAGCACTCCAGATGCTGCTCACCCGGGTCGGCGAGGTGGAGGCCCGGGACCGCGGCTTCGCCAGCGTCGTCGGCGGGACGCTCGGCTCCGAGGGGCCGCCCAGCACCATGCGGGCCGACCTGGAGGACGAGCTGGTGGACCTGGTCGGCAAGGGCCAGGCGGCCGGCTCCATCCGCACCGATATCGCGGGCGCCGACATCCTCGCGCTGACCTGCGGTCTCACCTCGATCGTGCACCGGCGCAGCGGCGACTGGCGGCGCTACATCGACATCGTGCTCGACGGATTGCGCTCCGACCGCGCCACGTCCTAG	VLNAARELFAERGANVSMDEVARRAEVGVGTLYRHFPTKEAMVVAASQQRFGEILTYYRTVCRESAEPLEALQMLLTRVGEVEARDRGFASVVGGTLGSEGPPSTMRADLEDELVDLVGKGQAAGSIRTDIAGADILALTCGLTSIVHRRSGDWRRYIDIVLDGLRSDRATS	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	81.13	gnl|BL_ORD_ID|2335|hsp_num:0	1213			42	198	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000236.1|Kinamycin_20 # 16132 # 16308 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.740	BGC0000236.1|Kinamycin_20 	16132	16308	+	Loose	500	21.557	linG	29.63	3002879	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	GTGGCCGGGTTCGCCTGGGTCACCCTCGAAGGCTCCGCCGTGGTGGCCGACGACCCGGTGCGGGTCACCGAGGGAGCGCGCCGCTACACCCGCCGCTACCGCTCCGGGCCGCCCAACCCGCCCGGCCGGGTGGTCGTGGAGATCTCGGTCGACCGGGTCATGAGCCTCAACGTCTGA	MAGFAWVTLEGSAVVADDPVRVTEGARRYTRRYRSGPPNPPGRVVVEISVDRVMSLNV	MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDRSGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLELFKSVTEPLNIELPRTVIAQAKRLLNESATPHNK	21.25	gnl|BL_ORD_ID|1730|hsp_num:0	1873			312	462	lincomycin
BGC0000236.1|Kinamycin_21 # 16371 # 16835 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000236.1|Kinamycin_21 	16371	16835	+	Loose	700	25.409	ADC-194	22.45	3006363	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	GTGGTACGGGGAGCGTCCTCCCCGTACCACCGCGCTCTTTTCGTGCTGTCCCGGCGGTCGCCCGCGTCAGCCTTGCGGGGCGCGGTGCCGGTCACCCAGATCATGCGCAGGGACAGCAGGCTGAGCCGCCAGCCCTCCGGGGTGCGGCGGGCCTCGGCGGTCACCAGGCTTCCGTTGGCGAATATCGGATCGCGGTCGGCGTCCTCCGGATGGTCGGACGGGTGGTGCACATGGGTGGAGACGATGTTGCACCGCAAAGAGGCCCGGTCGCCGTCGATTTCCACGACGGCGGGCGAACCGATGTGCTGCGTGCGCGCGAAGGCCGCGAGCGCCGTGCTGTGGTACTCGGCGAGTCCGGCGATCCCCTCGTGCCGGCTCATCGGGAACTCGACGACCGCGTCCTCGGTGAACAGCCCCCGGGCCCAGGCGTCGTCGAGCTTGTCGTCGTCCAGATTGATCAGGTAA	MVRGASSPYHRALFVLSRRSPASALRGAVPVTQIMRRDSRLSRQPSGVRRASAVTRLPLANIGSRSASSGWSDGWCTWVETMLHRKEARSPSISTTAGEPMCCVRAKAASAVLWYSASPAIPSCRLIGNSTTASSVNSPRAQASSSLSSSRLIR	MRFKKISCLLLPPLFIFNTSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSIQDKKVVNGSTIFELGSVSKLFTATAGGYAKTKGKISFEDTPGKYWKELKNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKEWKPKNQIGEYRQYSNPSIGLFGKIVGLSMNQPFSQVLEKTIFPSLHLKNSYVNVPKIQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQIGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKSNKVTAISKEPSIKIFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	40.21	gnl|BL_ORD_ID|2484|hsp_num:0	4259			726	1017	
BGC0000236.1|Kinamycin_23 # 17262 # 18494 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000236.1|Kinamycin_23 	17262	18494	+	Loose	600	247.669	Streptomyces venezuelae rox	40.86	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGTCCATCGATTACCGTCTGGTCGAGGGCGGTTCGTACGGAGCGCGCGGCATTCCCCAGTCGCGCACCGAGGGCGTGCTGGCGGGCTGGGCCGGACAGCTCGGCGCCGAGGTGCGGCGCGGGGTCGAGGTCACGGGCCTGGACAACGGCGCCGACGGCGTGAGCGTGGAGGTCAGCACCGCCGAGGGGCCCGCCACGCTGCGCGGCCGCTACCTGGTGGGCGCGGACGGCGCCCGCAGTGCGGTGCGCAAGCTCGCGGGCATCGACTTCCCGGGCACCGACCCGGCCATCGAGCTCCGGTTCGCCGACATCAGCGGGGTGCCGTTGCGCCCGCGCTTCAGCGGCGAGCGGGTGCCCGGCGGCATGGTCATGGTGCTGCCGCTCGGCCCGGAGCGCTGCCGGATCGTCTACTTCGACCGCAGCGAGCCGTTGCGCAAGAGCCCGGACCCGATCACCTTCGACGAGGTGGCCGAGGCGTTCAAGCGGCTGTCCGGCGAGGACATCAGCGGCGCCACCGTGCACTGGGTCTCCACCACCACCGATGTGAGCCGGCAGGCCGCCGAGTACCGCAGGGGCCGGGTCTTCCTGGCCGGCGACGCCGCCCACATCCATCTGCCCATCGGCGCCCAGGGAATGAGCGCCGGCGTGCAGGACGCGGTCAACCTCGGCTGGAAGCTCGCCCTGGAGATCAAGGGCCAGGCTCCCGAGGGCCTGCTCGACACGTACCACTCCGAGCGGCACCCGGTCGGCGCGCGGGTCCTCACCAACACGCTCGCCCAGCGGATCCTCTACCTCGGCGGCGACGAGATCACCCCGCTGCTCGATGTGTTCACCGAGCTCACCGGGTTCGAGGACGTCCAGAAGACGCTGATCGGCATGGTCACCGGCCTGGACATCCGCCATGACGTGGGCGAGGGCGACCATCCGCTCCTCGGCCGCCGTCTCAAGGACGAGGAGCTGGTGGTCGACGGCAAGAAGACCACCAACTTCGAACTCCTCGCGGCCGGCAAGGCCGTTCTGTTCAACCTCACCGATGACCCCCACCTGCGGGAGCTCGCCGCGGGCTGGGCCGACCGTGTCACCACGGTCACCGCCGAGCAGCACGACTGCGACAACGGTCTGGACGCCTTCCTGGTCCGTCCCGACGGCTATGTCGCCTGGGTCGCCCCTTCCGCGTCGCGCACGGAGGGGCTCGCCGAAGCACTCAACCGATGGTTCGGCCGGCCCAACTGA	MSIDYRLVEGGSYGARGIPQSRTEGVLAGWAGQLGAEVRRGVEVTGLDNGADGVSVEVSTAEGPATLRGRYLVGADGARSAVRKLAGIDFPGTDPAIELRFADISGVPLRPRFSGERVPGGMVMVLPLGPERCRIVYFDRSEPLRKSPDPITFDEVAEAFKRLSGEDISGATVHWVSTTTDVSRQAAEYRRGRVFLAGDAAHIHLPIGAQGMSAGVQDAVNLGWKLALEIKGQAPEGLLDTYHSERHPVGARVLTNTLAQRILYLGGDEITPLLDVFTELTGFEDVQKTLIGMVTGLDIRHDVGEGDHPLLGRRLKDEELVVDGKKTTNFELLAAGKAVLFNLTDDPHLRELAAGWADRVTTVTAEQHDCDNGLDAFLVRPDGYVAWVAPSASRTEGLAEALNRWFGRPN	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	86.13	gnl|BL_ORD_ID|4833|hsp_num:0	5820			285	1413	rifampin; rifaximin; rifapentine
BGC0000236.1|Kinamycin_24 # 18545 # 19234 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=CCCGA;rbs_spacer=14bp;gc_cont=0.677	BGC0000236.1|Kinamycin_24 	18545	19234	+	Loose	400	32.7278	catA4	36.36	3004657	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCCCAAGATTTCCTCTGATGACAAGCACCTGACCGTCCTCAACCTGTTCTCCACGGACGCCCCGGAGAAGCAGGAGGGTCTGCTCGGCGCGATGCGCGAGATCGTCGACGCGGCCGCCTACCCGGGCTGGATGTCGTCCACCGTGCACGCCGGCGTGGACAAGCCGGGCACGGCCAACTTCATCCAGTGGCGCAGCCGCGCGGACCTTGAGGACCGCTACGACGGCGAGGAGTTCAAGCACCGCACGCTCCCCCTCTTCGGCGAGCTGACCACCTCGATCCGGCTGCTCCAGAACGAGGTCGCGTACTCGCAGACCAAGTCGGGCGACAGCGTCGAGATCTCCCCGGCCCGCACCGACTTCACCGTCATCGCGGTCTTCGGTGTCGAGGAGAAGAACCAGGACGACCTGGTCGACGCGCTCGGCCCGTCGATGAAGTTCCTCAGCGACGTTCCCGGCTACGTCTCGCACACCGTCCTGAAGGGCATCGCGGCCCGTGGCCTTGAGGGCTCCTTCGTGGTCTCCTACTCGCAGTGGGAGAGCCAGGAGGCCTTCGTCGCCTACCAGGCCGTCGCGCAGGCCGACAAGCCCGCCGCCCGCCAGGACGCGGAGAAGCGCACCGGCTCGCTCCTGACGTCGGTGGACTCCAACACCTACCGCGTGGTCCACACCCGCGCGGCCGGCGAGTAA	MPKISSDDKHLTVLNLFSTDAPEKQEGLLGAMREIVDAAAYPGWMSSTVHAGVDKPGTANFIQWRSRADLEDRYDGEEFKHRTLPLFGELTTSIRLLQNEVAYSQTKSGDSVEISPARTDFTVIAVFGVEEKNQDDLVDALGPSMKFLSDVPGYVSHTVLKGIAARGLEGSFVVSYSQWESQEAFVAYQAVAQADKPAARQDAEKRTGSLLTSVDSNTYRVVHTRAAGE	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	105.53	gnl|BL_ORD_ID|2198|hsp_num:0	3357			18	174	chloramphenicol
BGC0000236.1|Kinamycin_25 # 19198 # 19506 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000236.1|Kinamycin_25 	19198	19506	-	Loose	590	23.8682	CGA-1	34.38	3004766	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CGA beta-lactamase	ATGTCCTTTCAAGGCGCCCCGGTTCAGGTCTACGTCCGGTTCGGTCAGGTTCCGCAAATGTCCCGCAGCCATGTCAGAGAACTCGCAGCGAAGAGCAGCGAGTCGGCGCGGAATTGTCACGTGGGCGTCAGGTGCCGTCAGGTCGCGAACCGGACCGTCTTGGCGGCGGAAAGGGGCGCGACCGGGCCCCAAAACGCCGGAACGCCCGGCTCCGCGAGGGGAGTCGGGCGTCCGTGCGTACGTGTCGTGCTGGAGCGGAACGCTCCGTCTCGTTACTCGCCGGCCGCGCGGGTGTGGACCACGCGGTAG	MSFQGAPVQVYVRFGQVPQMSRSHVRELAAKSSESARNCHVGVRCRQVANRTVLAAERGATGPQNAGTPGSARGVGRPCVRVVLERNAPSRYSPAARVWTTR	MKKTTLLFLLISAFSLAQTSLLEQKINSIIKNKKATVGVSVLGFENGFKYDKNGDKKLPMQSVFKFHIAAAVLNAVDQGKLSLDQKIMLNQSNLLENTWSPLRDKYPAGNIEIPLSEVIEYTVAKSDNNGCDILLRLLGGTQVVQKFMDSKGVKGFQIKYNEEDMHKDWNVQYENYSTTKSAADVLKKLYDGKLLSKKSTDYLMKVMLSTSTGLNKMVEQLPKNTPVARKTGASGKNNAGLTGAENEIGIVTLPNGKHYALAVFVSNSMETDAVNCRMISDISKEVWEYFNK	34.93	gnl|BL_ORD_ID|2529|hsp_num:0	3568			651	747	
BGC0000236.1|Kinamycin_26 # 19528 # 20004 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=CCCGC;rbs_spacer=15bp;gc_cont=0.665	BGC0000236.1|Kinamycin_26 	19528	20004	+	Loose	730	23.8682	mexX	33.33	3003034	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCATGATCCGGGGCGTGGTTCGCCACCGCTGATCCTCTCGCTCAACTCCCGCTCATGGCCCTCGCATTCGGGCGCGTCCGACGTCGTACGCGCAAGAGGCGGAGCCAGTGCCGGATCAACCGCAACCGCTGAGGAGCGAATACGTATGCACAGCACGCTCATCGTCGCCCGCATGGAACCCGGTTCGAGCACCGACGTCGCCAAGCTCTTCGCCGAGTTCGACGCGACGGAGATGCCGCACCGGATGGGAACGCTGCGCCGCCAGCTGTTCTCCTACCGGGGCCTCTACTTCCACCTGCAGGACTTCGACGCGGACAACGGCGGTGAGCTGATCGAGGCCGCGAAGAACGACCCGCGGTTCATCGGGATCAGCAACGACCTGAAGCCGTTCATCCAGGCGTACGACCCGGCCACCTGGCGCTCGCCCGCCGACGCCATGGCCACGCGCTTCTACAACTGGGAGGGGCGCGCGTGA	MHDPGRGSPPLILSLNSRSWPSHSGASDVVRARGGASAGSTATAEERIRMHSTLIVARMEPGSSTDVAKLFAEFDATEMPHRMGTLRRQLFSYRGLYFHLQDFDADNGGELIEAAKNDPRFIGISNDLKPFIQAYDPATWRSPADAMATRFYNWEGRA	MDRLAARLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRLEAYRQAEVRARVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALPGRGQPRAAADKLKAYADLIKDRAISEREYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPIDGRARRALVTEGALVGEDSPTPLTRVEQIDPIYVNFSQPAAKSRHAAGDPRRPGEGCRRQGHRRAPGPGRRQRVPLAGELLFIDLAVDPGTDTIAMRALFRNPHRELLPGGYVQVRLQRAVNPQAITVPDALIRTAQSAVVKVVNPKGLVEDVEVRADTLQGRDWIISRGLKGGEWVIVENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ	40.62	gnl|BL_ORD_ID|306|hsp_num:0	334			126	243	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000236.1|Kinamycin_28 # 21272 # 22483 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=CCCG;rbs_spacer=13bp;gc_cont=0.734	BGC0000236.1|Kinamycin_28 	21272	22483	+	Loose	1700	30.4166	AxyY	31.03	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGTCGTCCGTGGTGGTCACCGGCCTGGGGGTGGCGTCCCCCAACGGACTCGGCATCCAGGACTACTGGGCGGCGACCGTCGGTGGCAAGAGCGGCATCGGCCGTATCACCCGCTTCGACCCGTCGTCCTACCCGGCCAAGCTGGCCGGCGAGGTCCCGGGCTTCGTCGCGGAGGACCTGCTGCCCAGCCGCCTGCTCCCGCAGACCGACCGGGTCACCCGGCTGGCGCTCGTCGCCGCCGACTGGGCGCTCGCCGACGCGGGCATCACCCCCTCCGAACTCGGCGAGTTCGACATGGGCGTGGTGACCGCGAGCGCGGCCGGCGGCTTCGAGTTCGGCCAGGGCGAGCTCCAGGCGCTGTGGTCCAAGGGCAGCCAGTACGTCTCGGCGTACCAGTCCTTCGCCTGGTTCTACGCGGTCAACAGCGGCCAGATCTCCATCCGCAACGGGATGAAGGGCCCCAGCGGCGTGGTCGTCAGCGACCAGGCCGGCGGGCTCGACGCGGTGGCGCAGGCCCGGCGGCAGATCCGCAAGGGCACCAGCGTGATCGTGTCCGGCGCCATCGACGCCTCGGTCTGCCCGTGGGGCTGGGTGGCGCAGCTGGCCAGCGACCGGCTCTCCACCAGCGACGAGCCGACCCGCGCCTATCTGCCGTTCGACCGCGACGCCTCGGGCTATGTGGCGGGCGAGGGCGGCGCGATCCTGATCATGGAGGACGCCGAGTCGGCCCGCGCCCGTGGCGCCCGTGTCTACGGCGAGATCTCCGGCTACGGCTCGACCATCGACCCGAAGGCCGGCTCCGGCCGCCCGCCGGGGCTGCGCAAGGCCATCGAACTCGCCCTGGCGGACGCGGGGGTCGCCCCGGGTGAGGTGGACGTGGTCTTCGCCGACGCGGCCGCCGACCCCGAGCTCGACCGGCAGGAGGCCGAGGCCATCAACGCCGTGTTCGGCACCCGCGGCGTGCCGGTCACCGCTCCCAAGACGATGACCGGACGGCTCTACTCGGGCGCCGCCCCGCTGGACCTGGCCGCCGCCTTCCTCGCCATGAAGGACGGTCTGATCCCGCCGACCGTGCACATCGATCCGGCCGCCGAGTACGACCTGGATCTGGTCACCGGCGAGCCGCGCACCGCCGAGGTGCGCACCGCGCTGGTCGTGGCCCGCGGCTACGGCGGGTTCAACTCCGCGGTGGTCGTGCGCGCCGCGTAG	MTSSVVVTGLGVASPNGLGIQDYWAATVGGKSGIGRITRFDPSSYPAKLAGEVPGFVAEDLLPSRLLPQTDRVTRLALVAADWALADAGITPSELGEFDMGVVTASAAGGFEFGQGELQALWSKGSQYVSAYQSFAWFYAVNSGQISIRNGMKGPSGVVVSDQAGGLDAVAQARRQIRKGTSVIVSGAIDASVCPWGWVAQLASDRLSTSDEPTRAYLPFDRDASGYVAGEGGAILIMEDAESARARGARVYGEISGYGSTIDPKAGSGRPPGLRKAIELALADAGVAPGEVDVVFADAAADPELDRQEAEAINAVFGTRGVPVTAPKTMTGRLYSGAAPLDLAAAFLAMKDGLIPPTVHIDPAAEYDLDLVTGEPRTAEVRTALVVARGYGGFNSAVVVRAA	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	38.56	gnl|BL_ORD_ID|2411|hsp_num:0	2799			2007	2244	erythromycin; cefepime
BGC0000236.1|Kinamycin_29 # 22588 # 22854 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000236.1|Kinamycin_29 	22588	22854	+	Loose	900	26.5646	iri	60.87	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGCCACCACGTTCACCCTCGACGACCTCAAGCGCATCCTCCTTGAGGCAGCCGGCGCCGACGAGGGCGTCGACCTGGACGGCGACATTCTGGACACCGAGTTCGAGGTCCTGGGATACGAGTCGCTCGCCCTGCTGGAGACCGGCGGCCGCATCGAGCGCGAGTACGGCATCTCGCTGGACGACGACGCGCTGACCGACGCGGTCACCCCGCGCGCCCTCATCGAGGTCGTCAACGCCCAGCTGTCCGCCGCGTCCGCCGCCTGA	MATTFTLDDLKRILLEAAGADEGVDLDGDILDTEFEVLGYESLALLETGGRIEREYGISLDDDALTDAVTPRALIEVVNAQLSAASAA	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	18.37	gnl|BL_ORD_ID|729|hsp_num:0	796			678	747	rifampin; rifaximin; rifabutin; rifapentine
BGC0000236.1|Kinamycin_30 # 22880 # 23665 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000236.1|Kinamycin_30 	22880	23665	+	Loose	750	33.4982	mdtH	25.66	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGAGAACACCGCACGGGTCGCGCTGGTCACGGGTGCCACGAGCGGCATCGGGCTCTCCGTCGCCCGGCTGCTCGGCTCGCAGGGCCACAAGGTCTTCATCGGCGCGCGCAACGCCGACAACGTCGCCGAGACGGTCAAGCAGCTCCAGGGCGAGGGCCTGGAGGCCGACGGCTCGGCGCTCGACGTCACCGACGCCGCCAGCGTCAAGGCCTTCGTCCAGGCGGCCGTCGACCGCTTCGGCACCGTCGACGTGCTGGTGAACAACGCCGGCCGCTCCGGTGGCGGCGTCACCGCCGACATCGAGGACGAGCTGTGGGACGCCGTCATCGACACCAACCTGAACAGCGTCTTCCGGGTCACCCGTGAGGTCCTGAACACCGGTGGCATGCGCCACAAGGACCGCGGCCGGATCATCAACATCGCCTCCACCGCGGGCAAGCAGGGCGTGGTGCTCGGCGCCCCGTACTCGGCCTCCAAGCACGGTGTGGTCGGCTTCACCAAGGCCCTGGGCAACGAGCTCGCGCCCACCGGCATCACGGTCAACGCCGTCTGCCCCGGCTACGTCGAGACGCCGATGGCGCAGCGCGTGCGCCAGGGCTACGCGGCCGCGTACTCCACCTCCGAGGACGCGATCCTGGAGAAGTTCCAGTCCAAGATCCCGCTCGGCCGCTACTCCACCCCGGACGAGGTCGCCGGTCTGGTCGGCTACCTCGCCTCGGACACGGCCGCGTCCATCACCGCGCAGGCGCTCAACGTCTGCGGCGGCCTCGGCAACTTCTAG	MTENTARVALVTGATSGIGLSVARLLGSQGHKVFIGARNADNVAETVKQLQGEGLEADGSALDVTDAASVKAFVQAAVDRFGTVDVLVNNAGRSGGGVTADIEDELWDAVIDTNLNSVFRVTREVLNTGGMRHKDRGRIINIASTAGKQGVVLGAPYSASKHGVVGFTKALGNELAPTGITVNAVCPGYVETPMAQRVRQGYAAAYSTSEDAILEKFQSKIPLGRYSTPDEVAGLVGYLASDTAASITAQALNVCGGLGNF	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	64.93	gnl|BL_ORD_ID|342|hsp_num:0	375			117	456	enoxacin; norfloxacin
BGC0000236.1|Kinamycin_31 # 23692 # 24627 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=CCCGA;rbs_spacer=13bp;gc_cont=0.683	BGC0000236.1|Kinamycin_31 	23692	24627	+	Loose	525	26.1794	OKP-B-12	30.91	3002445	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGACGACCCGCGAGGTCGAGCACGAGATCACCATCGAGGCCCCCGCCGCCGCCGTGTACCGGCTGCTGGCGGAGGTCACCAACTGGCCGCGGATCTTCCCGCCGACGATCTACGTCGACCAGGTGGGCGAGCACGACAACCACGAGCGCATCCGGATCTGGGCCACCGCCAACGGCGAGGCCAAGAACTGGACCTCGCACCGTGAGCTCGACCCCGAGGCGCTGCGGATCACCTTCCGCCAGGAGGTCACCACGCCGCCGGTCGCCGCGATGGGCGGCACCTGGATCATCGAGACCCTGGGCGAGACCACCTCGCGGGTCCGGCTGCTCCACGACTACCGGGCGATCGACGACGACCCCGAGGGGCTGGCCTGGATCGACGAGGCGGTCGACAAGAACAGCCGCTCGGAGCTGGCCGCGCTGAAGCAGAACGTCGAACTGGCCCACGCGACCGAGGAGGTGACGTTCTCGTTCACCGACACCGTCATCGTCCAGGGCTCGCCCAAGGACCTGTACGACTTCATCAACGAGGCGAACCTGTGGTCCGAGCGGCTGCCGCACGTGGCCGTCGTCCGGCTCACCGAGGACACCCCGGGGCTGCAGACCCTGGAGATGGACACCCGCGCCAAGGACGGCTCGGTGCACACCACCAAGTCGTACCGGGTGACCTTCCCGCACCACAAGATCGCGTACAAGCAGGTCACGCTGCCCGCGCTGATGACCCTGCACACCGGGATCTGGACGTTCGAGGAGACGCCCGAGGGCACGGCCGCCTCCTCGCAGCACACCGTCACGCTCAACACGGACAACATCGCGAAGATCCTCGGCCCCGAGGCCACCGTCGCGGACGCCCGTGAGTACGTGCACACCGCGCTGTCCACCAACAGCACGGCGACGCTCAACCACGCCAAGACGTACGCCGAGTCGAAGGGCTGA	MTTREVEHEITIEAPAAAVYRLLAEVTNWPRIFPPTIYVDQVGEHDNHERIRIWATANGEAKNWTSHRELDPEALRITFRQEVTTPPVAAMGGTWIIETLGETTSRVRLLHDYRAIDDDPEGLAWIDEAVDKNSRSELAALKQNVELAHATEEVTFSFTDTVIVQGSPKDLYDFINEANLWSERLPHVAVVRLTEDTPGLQTLEMDTRAKDGSVHTTKSYRVTFPHHKIAYKQVTLPALMTLHTGIWTFEETPEGTAASSQHTVTLNTDNIAKILGPEATVADAREYVHTALSTNSTATLNHAKTYAESKG	TALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASERFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLKSVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERNQQIAG	118.25	gnl|BL_ORD_ID|1189|hsp_num:0	1296			396	555	
BGC0000236.1|Kinamycin_32 # 24635 # 26107 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000236.1|Kinamycin_32 	24635	26107	+	Loose	550	305.834	Nocardia farcinica rox	43.49	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCCCGGACCGCCTGGACACACAGGTCATCGTCGTCGGCGCCGGCCCCGTCGGGCTTCTGCTCGCCGGTGAGCTGCGTCTTGGCGGCGCCGACGTGGTCGTACTGGAACAACGGGCCACGCCCACCACGGAGTCGAGGGCCTCCACGCTGCACGCCCGCACCATGGAGCTCCTTGACAGCCGCGGCCTGCTCGACCTGTTCGGGACGCCGCCGAACGAGCCGCGCGGCCACTTCGGCGGCATCCCGATGGACCTCACGCTGCCCAGCCCCTTCCCGGGGCAGTGGAAGATGCCCCAGACCCGGACCGAGGCGCTGCTCCAGGAGTGGGCGCTGTCGCTGGGCGCGGACATCCGGCGCGGCCACGAGCTGGTCGCCGTGTCCGACGAGGGCGACTTCGTCGAGGCCCGGGCGGCCGGGCCGGAGGGCACGGTCGTGGTGCGCGGGCGGTTCCTCGTCGGGTGCGACGGCGAGGAGTCGGCCGTGCGCCGCCTGACGGGCGCCGAGTTCCCGGGCAACGACGCCGGCCGCGAGCTGCTGCGCGCGGACGTGGCCGGTGTCACCATCCCGGGCCGCCGCTTCGAGCGGCTGCCCGCCGGGCTCGCCATCGCGGCGACCCGCGACGGGGTGACCCGGGTGATGGTGCACGAGTTCGGCTCCCAGGCCGAACCCCGCACCGGCGACCCGGAGTTCGGCGAGATCGCGGCGGTCTGGAAGCGCGTCACCGGCGAGGACATCAGCGGCGGAACCCCGCTGTGGGCGAACTCGTTCGGCGACGCCAACCGCCAGCTCACGCACTACCGCGACGGCCGGATCCTGTTCGCCGGCGACGCGGCCCACCGGCAGATGCCGATCGGCGGCCAGGCCCTCAACCTGGGCCTCCAGGACGCCTTCAACCTGGGCTGGAAGCTGGCTCTGCACCTCGGCGAGTCGGCCCCCGAGGGCCTGCTCGACACGTACCACAGCGAGCGGCACGAGGTCGGCCGGCGGGTGCTTTCCAACATCAGGGCACAGGCCATGCTGCTGCTCGGCGGCCAGGAGGTCGAGCCGCTGCGCGCGGTGCTGACCGAGCTCCTGCCGTACGACGACGTCCGGGCGCACCTCGCCGGGATGATCAGCGGCCTCGACATCCGTTACGACGTGGGCGGCCCCGAGCACCCGCTGCTCGGCGCACGGCTGCCGGACGCCGGTCTCACCACCGGCGAAGGCCCGCTGAGCACCGCCCAGTTGCTGCGCACCGCACGCGGTGTGCTCCTCGACCTGTCCGGTGGCAGTGCGGTGCTGTCGGACGCCGCCGGCTGGGCGGACCGGGTCACCGCTCTGCCCGCCGTGCCGGAGAAGGGCGGCGCCCTCGACTCGGTGGGCGCCGTCCTGGTCCGGCCCGACGGCCATGTGGCCTGGGCCGGCGCCCCGGACACCGACGGCGCCGGGCTGCGGGAGGCCCTGGAGCGCTGGTTCGGCCCCTCGCACTGA	MTPDRLDTQVIVVGAGPVGLLLAGELRLGGADVVVLEQRATPTTESRASTLHARTMELLDSRGLLDLFGTPPNEPRGHFGGIPMDLTLPSPFPGQWKMPQTRTEALLQEWALSLGADIRRGHELVAVSDEGDFVEARAAGPEGTVVVRGRFLVGCDGEESAVRRLTGAEFPGNDAGRELLRADVAGVTIPGRRFERLPAGLAIAATRDGVTRVMVHEFGSQAEPRTGDPEFGEIAAVWKRVTGEDISGGTPLWANSFGDANRQLTHYRDGRILFAGDAAHRQMPIGGQALNLGLQDAFNLGWKLALHLGESAPEGLLDTYHSERHEVGRRVLSNIRAQAMLLLGGQEVEPLRAVLTELLPYDDVRAHLAGMISGLDIRYDVGGPEHPLLGARLPDAGLTTGEGPLSTAQLLRTARGVLLDLSGGSAVLSDAAGWADRVTALPAVPEKGGALDSVGAVLVRPDGHVAWAGAPDTDGAGLREALERWFGPSH	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	103.59	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	1416	rifampin
BGC0000236.1|Kinamycin_33 # 26200 # 27702 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000236.1|Kinamycin_33 	26200	27702	+	Loose	550	329.717	Nocardia farcinica rox	43.69	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGAGGGGACAGCCGTGGACACCGATGTGATCATCGTCGGCGCGGGTCCGACCGGCCTCATGCTCGCCGGGGAACTGCGCCTCGGCGGGGCGGACGTCGTCGTCGTCGAACGGCTGACGAAGCCCACCGGCCAGTCCCGGGGCCTGGGCTTCACCGCCCGCGCCATGGAGATCTTCGACCAGCGCGGGCTGCTGCCCCGGTTCGGCCAGGGCGAGACGCTGGAGATCAGCCCGCTCGGTCACTTCGGCGGTGTGCAGTTCGACTACACCGTCCTGGAGGGCGCCCACTTCGGGGCGCGCGGCATTCCCCAGAACATCACCGAGACGGTCCTTGAGGAGTGGGCGACCGAGCTCGGCGTGGACATCCGGCGCGGCTGGGACTTCCTGGAGATAGCCGACGGCTACCTCGACGGCGACAGCGTCGAGATCAAGGTGCAGACGCCCAACTCGGTACGGAAGCTGCGCGCTTCCTACCTCGTGGGCGCCGACGGCGGCCGCAGCGTGGTGCGCGAGGCGGCCGGGTTCGACTTCCCGGGCACCTCGGCCACCCGGGCGATGTTCCTGGCCGATGTGACCGGCTGCAACCTCAAGCCGCGCTTCCTCGGTGAGCGGCTGAACAACGGCATGGTGATGGCGGCCCCGCTCGCCGAGGGCGTCGACCGCATCATCGTCTGCCCGGACGGCACGCCCGCGCGCGCCAGCGGCGACACGGTCAGCTTCGAGGAGGTCGCCGCCGCCTGGCAGTCGATCACCGGCGAGGACATCTCGCACGGCGGCGCCGAGTGGGTCAGCTTCTTCAGCGACGCCACCCGCCAGGCCTCCGAGTACCGGCGCGGCCGGGTCCTGCTGGTCGGCGACGCCGCCCACATCCACCTCCCGGCCGGCGGCCAGGGCCTGAGCACCGGCGTCCAGGACGCGGCCAACCTCGGCTGGAAGCTGGCCGCGGCGGTCGCCGGGACCGCGCCCGAGGGGCTGCTCGACACGTACCACGGCGAGCGCCACCCCGTGGGTGCCCGGCTGCTGATGAACACCCGCGCCCAGGGCATGGTGTTCCTCGGCGGACCCGAGGCCGAGCCGCTGCGCCAGCTCTTCGGCGAGCTCATCCAGTACGACGACGTGAAGCGCCATCTCGCCGGGATCGTCAGTGGTCTGGACATCCGGTACGAGCTGGGTGACGCGCACCCGCTGGTGGGGCGCCGGATTCCGCCTCGGCGGCTGGTGGGGGCGGCGGGGGAGACCAGCACCGTCGCGCTGCTGCACGCGGCGCGGGGTGTGCTGCTCGACTTCGCCGACGACGCGGCGGTGCGGGACGCGGCCGCCGGGTGGTCGGGGCGCGTCGACGTCGTCACGGCGGCGCCGAAGCCGGTCGACGGCGGTACCGATCCGCTCGCGGGTGCGGCTGCCGTGCTCGTACGGCCCGATGGATATGTGGCGTGGGCCGCGGACACGGCCGAAGGCCTTGCTCCGGCTCTTGAGCGCTGGTTCGGTCCGGCCGGGGTGTGA	MEGTAVDTDVIIVGAGPTGLMLAGELRLGGADVVVVERLTKPTGQSRGLGFTARAMEIFDQRGLLPRFGQGETLEISPLGHFGGVQFDYTVLEGAHFGARGIPQNITETVLEEWATELGVDIRRGWDFLEIADGYLDGDSVEIKVQTPNSVRKLRASYLVGADGGRSVVREAAGFDFPGTSATRAMFLADVTGCNLKPRFLGERLNNGMVMAAPLAEGVDRIIVCPDGTPARASGDTVSFEEVAAAWQSITGEDISHGGAEWVSFFSDATRQASEYRRGRVLLVGDAAHIHLPAGGQGLSTGVQDAANLGWKLAAAVAGTAPEGLLDTYHGERHPVGARLLMNTRAQGMVFLGGPEAEPLRQLFGELIQYDDVKRHLAGIVSGLDIRYELGDAHPLVGRRIPPRRLVGAAGETSTVALLHAARGVLLDFADDAAVRDAAAGWSGRVDVVTAAPKPVDGGTDPLAGAAAVLVRPDGYVAWAADTAEGLAPALERWFGPAGV	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	105.71	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1416	rifampin
BGC0000236.1|Kinamycin_34 # 27986 # 28735 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=CCCCGC;rbs_spacer=15bp;gc_cont=0.741	BGC0000236.1|Kinamycin_34 	27986	28735	+	Loose	1850	25.409	mdtF	31.82	3000796	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCACGGCGGCGGGATGAGCGCCGGGTACTTCGACGGTCAGGCGCACCCCGAGCTGTCCCTGCTCACCCTCGGCGCCCGGCTCGGCTACACCGTGCTCGCGGTGGACCGGCCCGGCTACGGCCGTTCCGCCGCCCAGCTGCCGGACGGGCTCACCGTCGCCGAGCAGACCGAGGTGCTGCGGGCCGGGATCGACGACTTCACCTCCAAGTACCCGACGGGCGCGGGGGTGTTGCTGGTCGCCCACTCCTTCGGCGGCAAGCTCGCCCTGTCGGCCGCCGCGCACTGCACCGGCGACGGCCTGCTCGGCATCGACATCTCCGGCTGCGGCCACCGCTACGCCGTCACCCCGGGCGTGCTGCGCAAGGGCCTCAAGCACATCGCCCGGCACTGGGGCCCGCTGCGGCTCTACCCGCCGGACACCTTCCGCAGCAGCGGCTCCCTGGTGGCGCCGATGCCGGAGCGCGAGGCGAGTGAACTCAAGCGCTGGCCCGAGCTGTTCGCGGCCCTCGCGCCGCGCGTGCGGATCCCGGTCCGGCTCACCTTCGCCGAGCACGAGGGCTGGTGGCTGCACGGCGAGCAGGACCTCGCCGACCTCGCCGCCCAGCTGACCGCCTCGCCCCGTATCGTCGTCGACCGCCAGCCGGACGCCGGTCACAACATCAGCCTCGGCTGGGCGGCCCGCTCCTACCACCTGCGCACCCTCGCGTTCCTGGAGGACTGCATCACGCGGGCGGGACGCGATGGGTGA	MHGGGMSAGYFDGQAHPELSLLTLGARLGYTVLAVDRPGYGRSAAQLPDGLTVAEQTEVLRAGIDDFTSKYPTGAGVLLVAHSFGGKLALSAAAHCTGDGLLGIDISGCGHRYAVTPGVLRKGLKHIARHWGPLRLYPPDTFRSSGSLVAPMPEREASELKRWPELFAALAPRVRIPVRLTFAEHEGWWLHGEQDLADLAAQLTASPRIVVDRQPDAGHNISLGWAARSYHLRTLAFLEDCITRAGRDG	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	24.01	gnl|BL_ORD_ID|103|hsp_num:0	121			1665	1797	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000236.1|Kinamycin_35 # 28745 # 30025 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000236.1|Kinamycin_35 	28745	30025	+	Loose	800	68.9366	mef(B)	20.46	3003107	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCAGCACTCTGGCAACCCCTTTCCGTTCCCTGTCCGTACGGAACTTCCGGCTGTTCGCGGCCGGGCAGGTGGTCTCCGTCGCGGGCACCTGGATGATGGTCGTGGCCCAGGACTGGATCGTCCTGAGCCTGGCCGACAACTCCGGTACGGCGCTGGGCGTGGTGACCGCGCTGCAGTTCACCCCGCTGCTGCTGCTCACCCTGTACGGCGGGCGCCTCGCCGACCGCTACGACAAGCGCTTCCTGCTGACCTGTGCCAATCTCGCGTCCGGCGCGCTGGCTCTGGTGCTCGCGCTGCTCGCGTTCGCGGACGCGGTGCAGCTGTGGCACATCTGGCTGTGCGCGTTCGGCCTCGGGATGGTGAACGCCGTCGAGGTGCCGACCCGGATGGCGTTCGTCAGCGAGCTGGTCGGCCCCGAACTGCTGCCCAACGCCTCCGCATTGAGCGCCGCGTACTTCAACACCGCCCGGGTCGTCGGCCCGGCGCTGGCCGGGCTGCTCATCACCGGCTTCGGCACCGGCTGGGTCATGCTGTTCAACTCCGTCAGCTATCTGGCCACGGTGGCCGGGCTGCGGATGATGCGGCCGGACGAACTGCTGCGCGGCGCACGGCAGGACACCCGTCCCCGGGTGATCGACGGGCTGCGGTACATCCGCAGCCGCCCCGATCTGAAGCTGCCGCTCGCCCTGATCGGGGTGATCTCGCTCGTCGGGCTCAACTTCCAGCTGACGCTGCCGCTGTATGCCAAAACGGTTTTCCACGCCGACGCGGCCTCGTTCGGGCTGCTGACCACCGGCTTCGCGGCGGGCTCCCTGGTCGCCGCGTTCGTCACCACGGCGCGCCGCGGCCGCCCCTCCAGCCGTCTGGTGGTCGCCTCGGCGATCGCGTTCGCGGCCTTGGAGACGGTGGCGGGCTGGGCGCCCAACTTCGCCTCGGCGATCGTGCTGCTCTCGCTCACCGGCGGGGCGACCATCTACTTCGTCCAGGCGGCCAACCATCGCGTCCAGCTCGGCAGCGACCCGCAGTACCGGGGCCGGGTGATGGCGCTCTACACGCTCATCGTCCAGGGCTCCACCCCGCTGGGATCGCTCCTCATCGGCTGGCTCGCCGAACACCTGGGCGCCCGCTCGGGGTTCTACGTGGGCGGCCTGGTCTCGCTGGCGGCCGCCCTGACGGCGCTGGCCTTCGACCGGCGTACGGGACAGGAGGCGTCCGACGACGTGACGACGGCGACGAAGGCCGCGCCCGAGGGCGAGCCCGAGGCGGTGAGCCGGTGA	MTSTLATPFRSLSVRNFRLFAAGQVVSVAGTWMMVVAQDWIVLSLADNSGTALGVVTALQFTPLLLLTLYGGRLADRYDKRFLLTCANLASGALALVLALLAFADAVQLWHIWLCAFGLGMVNAVEVPTRMAFVSELVGPELLPNASALSAAYFNTARVVGPALAGLLITGFGTGWVMLFNSVSYLATVAGLRMMRPDELLRGARQDTRPRVIDGLRYIRSRPDLKLPLALIGVISLVGLNFQLTLPLYAKTVFHADAASFGLLTTGFAAGSLVAAFVTTARRGRPSSRLVVASAIAFAALETVAGWAPNFASAIVLLSLTGGATIYFVQAANHRVQLGSDPQYRGRVMALYTLIVQGSTPLGSLLIGWLAEHLGARSGFYVGGLVSLAAALTALAFDRRTGQEASDDVTTATKAAPEGEPEAVSR	MNRIKNWKKQFAVIYTGQAFSILGSAAVQFAVIWWLTIQTESAITLTIASLVAFLPNMLIGPFAGVWIDRYNRRTVMILADGLVAVSSIILGAAFLLVETPPIWFIYIVLFLRGLGNTFHGPAMQAAIPMFVPADMLTKAGGWGNMIQSISNMMGPVLGAALMSFLPISSIMIVDILGAAFAIVCLLFVIIPDITQTNEKMSVLSDMKQGFIAMKANKPLMAVFSPMLLMTILYMPLGSLFPLLARSHFMGEAWHNSIVEFVFAGGLLLSSLVIGVWGGMKRRFFMASLAIGLMGLATLISGALPTSGFWIFVICCFFLGASGTFMNVPVMAYVQESIAPEMMGKVFSLLMTAMTLSMPIGLLVAGPVVEVIGVNTWFFWSGVALIVNAVLCRILTRRYDKVTMKPQVD	104.16	gnl|BL_ORD_ID|1198|hsp_num:0	1198			24	1194	
BGC0000236.1|Kinamycin_36 # 30022 # 30711 # 1 # ID=1_36;partial=00;start_type=GTG;rbs_motif=CCCG;rbs_spacer=13bp;gc_cont=0.758	BGC0000236.1|Kinamycin_36 	30022	30711	+	Loose	550	25.0238	vgbA	40.74	3001307	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	GTGAACGCGACCGTGACACCGGTGAACGCCACCGTGACGCCGCTGAAGGCGCCGCCCGGGGCGGGCCTGCTGCATCTGGTCGTCTTCCGGCCGCCCGTCGAGGACGCGGCGCCGGTGTGCCCGCTGATGCAGGCCCTGGACGAGCTGGAGGCGGCCCGCGCGGCCACCTTCGTCCACGACAGGGACCGCCGCCAGTACGTGGCGGCGCACGCCACCCTGCGGCGCGTGCTCGCCGAGTACACCGGGCACGAGCCCAGCCGGGTGCCGCTCGGCCGGGCCGAAGGGCCCTACGGGAAGCCGCAGTTGATCGGTTCGCCGGTCCCGCTGCACTTCAACCTCTCGCACAGCCACGGCCTGATCGCCATCGGGGTCGCGGCGGACCCGGTGGGCGTCGACGTCCAGCGCGTCCCGTCGCCCGAGGCGGTCGAGGTGGTCCTGCCCAGGCTGCATCCGCGCGAGCGCGAGGAACTGCGCGCTCTGCCCGCATCGGAGCGCCCGGAGGCGTTCGCGCGGCTGTGGACCCGCAAGGAGGCCTACCTCAAGGGCCTGGGCACCGGCCTCACCCGCTCGCCCGCGGCGGACTATCTGGGCGAGACGGCCGCGGCCCGCCCGGCCGGCTGGACGGTGCGCAACGTGCCGGTACAGCCGGGCTACGCGGCCGCGGCCGCGCTCCGCCACCACCCGACCTGA	MNATVTPVNATVTPLKAPPGAGLLHLVVFRPPVEDAAPVCPLMQALDELEAARAATFVHDRDRRQYVAAHATLRRVLAEYTGHEPSRVPLGRAEGPYGKPQLIGSPVPLHFNLSHSHGLIAIGVAADPVGVDVQRVPSPEAVEVVLPRLHPREREELRALPASERPEAFARLWTRKEAYLKGLGTGLTRSPAADYLGETAAARPAGWTVRNVPVQPGYAAAAALRHHPT	MEFKLQELNLTNQDTGPYGITVSDKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVMCLTISSDGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITEGPNGDIWFTEMNGNRIGRITDDGKIREYELPNKGSYPSFITLGSDNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGNDDALWFVEIIGNKIGRITPLGEITEFKIPTPNARPHAITAGAGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAMECDKIGKLTLIKDNME	76.59	gnl|BL_ORD_ID|4682|hsp_num:0	1594			249	330	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000236.1|Kinamycin_37 # 30771 # 32351 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	BGC0000236.1|Kinamycin_37 	30771	32351	+	Loose	700	26.5646	ACT-53	25.68	3006248	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCCGACCACGCCGACCACACAGTCCTCCGCCGAGGTCTCCGACCGGCTGGACGAACTCAGCGAACGCAAGGAACAGGCCGTACGCGGTCCCAGCGACAAGGCGACCGAGGCGCAGCACGCCAAGGGCAAGCTGACCGCACGCGAGCGGATCGAACTCCTCCTGGACAAGGGCAGCTTCACCGAGGTCGAGCAGCTGCGGCGGCACCGCGCCACCGGGTTCGGCCTGGAGGCCAAGAAGCCGTACACGGACGGTGTCATCACCGGCTGGGGCACGGTCGAGGGCCGTACGGTCTTCGTCTACGCCCATGACTTCCGCATCTTCGGCGGCGCGCTCGGCGAGGCCCACGCGACCAAGATCCACAAGATCATGGACATGGCGCTGGCGGCGGGCGCGCCGCTGGTCTCGCTGAACGACGGCGCGGGCGCCCGGATCCAGGAGGGCGTCTCGGCGCTCGCCGGTTACGGCGGCATCTTCCAGCGCAACACGCGGGCCTCGGGTGTCATCCCGCAGATCTCCGTGATGCTCGGCCCGTGCGCGGGCGGCGCGGCGTACTCGCCGGCGCTGACCGACTTCGTGTTCATGGTCCGCGAGACCTCGCAGATGTTCATCACCGGCCCGGACGTCGTCCAGGCCGTGACGGGCGAGGAGATCAGCCAGAACGGACTCGGCGGCGCCGATGTGCACGCCGGGACCTCGGGCGTGGCGCACTTCGCGTACGACGACGAGGAGAGCTGCCTCGCCGAGGTGCGCTATCTGCTCTCCCTGCTGCCGTCCAACAACCGGGAGATGCCGCCGCTGGCGCAGACCTCGGACCCGGTGGACCGCGAGGGCACCGCCCTGCTCGATCTGGTGCCGGCCGACGGCAACCGCTCGTACGACGTGCGCGGGGTGATCGAGGAGCTCGTCGACGACGGCGAGTACATGGAGATCCACGCCAACTGGGCGCCCAACCTGGTGGTGGCCCTGGCCCGGCTGGACGGCCATGTCGTCGGCGTCGTCGCCAACCAGCCGTCCGCCATGGCCGGCGTCCTGGACATCAAGGCGAGCGAGAAGGGCGCCCGGTTCGTCCAGTTCTGCGACTCCTTCAGCATCCCGCTGATCACCCTCGTCGACGTGCCCGGGTTCCTGCCGGGCGTCGACCAGGAGCACGACGGCATCATCCGGCGCGGCGCGAAGCTGCTCTACGCCTACTGCAACGCGACCGTGCCTCGTATCTCGGTGGTGCTGCGCAAGGCGTACGGCGGTGCCTACATCGTGATGGACTCGCGTTCCATCGGAGCCGACCTGTCGTTCGCCTGGCCCACCAACGAGATCGCGGTGATGGGCGCCGAGGGCGCGGCGAACGTGGTGTTCCGGCGGGAGATCGCCGCGGCCGAGGACCCGGACGCGATGCGCAAGCAGAAGATCGACGAGTACAAGAACGAGCTGGTGCACCCCTACTTCGCGGCCGAGCGCGGTCTGGTCGACGACGTCATCGACCCGCGCGAGACCCGCTCGGTGCTGTGCCGCTCGGTCACGATGCTCATCGCCAAGGACGCCGAGCTGCCCCGCCGCAAGCACGGCAACCCGCCCCAGTAG	MPTTPTTQSSAEVSDRLDELSERKEQAVRGPSDKATEAQHAKGKLTARERIELLLDKGSFTEVEQLRRHRATGFGLEAKKPYTDGVITGWGTVEGRTVFVYAHDFRIFGGALGEAHATKIHKIMDMALAAGAPLVSLNDGAGARIQEGVSALAGYGGIFQRNTRASGVIPQISVMLGPCAGGAAYSPALTDFVFMVRETSQMFITGPDVVQAVTGEEISQNGLGGADVHAGTSGVAHFAYDDEESCLAEVRYLLSLLPSNNREMPPLAQTSDPVDREGTALLDLVPADGNRSYDVRGVIEELVDDGEYMEIHANWAPNLVVALARLDGHVVGVVANQPSAMAGVLDIKASEKGARFVQFCDSFSIPLITLVDVPGFLPGVDQEHDGIIRRGAKLLYAYCNATVPRISVVLRKAYGGAYIVMDSRSIGADLSFAWPTNEIAVMGAEGAANVVFRREIAAAEDPDAMRKQKIDEYKNELVHPYFAAERGLVDDVIDPRETRSVLCRSVTMLIAKDAELPRRKHGNPPQ	MMTKTLCCALLLSTSCSALAGPLSEKQLAEVVEQTVTPLMKAQAIPGMAVAVIYEGQPHYFTFGKADVAKNKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQWQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVQPSGMSYEQAITTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPEALQDTSLGQGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVEAAYRILDALQ	138.06	gnl|BL_ORD_ID|3106|hsp_num:0	4144			363	567	
BGC0000236.1|Kinamycin_27 # 20034 # 21275 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	BGC0000236.1|Kinamycin_27 	20034	21275	+	Loose	750	182.956	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.16	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGAGGTCCTCGCCCCCGGTGGCATCGGCACCAAGAACTTCTGGAGCCTCCTCAGCGAGGGCCGCACGGCGACCCGGGGGATCACGTTCTTCGACCCCACGCCGTTCCGCTCGCGGGTGGCCGCCGAGATCGACTTCGACCCGTACGAGCACGGTCTGAGCCCGCAGGAGGTCCGCCGCATGGACCGGGCCGGCCAGTTCGCGGTCGTCGCCTCGCGCGGCGCGGTCGCCGACAGCGGTCTGGAGCTCGCCGGCCTCGACCCGTACCGGGTCGGTGTCACGGTCGGCAGCGCGGTCGGCGCCACCATGGGCCTGGACGAGGAGTACCGGGTCGTCAGCGACGGCGGCCGGCTCGACCTCGTGGACCACCAGTACGCGGCCCCGCACCTCTACAACCACCTGGTGCCGAGCTCGTTCGCGGCCGAGGTGGCCTGGGCGGTCGGCGCCGAGGGCCCCAGCACCGTGGTCTCCACGGGCTGCACCTCCGGCATCGACTCGGTCGGCTACGCCGTCGAGCTGATCCGCGAGGGCTCCGCCGACGTCATGATCGCCGGATCCTCGGACGCGCCGATCTCGCCGATCACCATGGCGTGCTTCGACGCGATCAAGGCCACGACGAACCGTTACGACGAGCCCGAGACGGCCTCGCGGCCGTTCGACAACTCGCGCAACGGCTTCGTCCTGGGCGAGGGCACCGCGTTCTTCGTCCTGGAGGAGCTGGAGAGCGCCGTCAAGCGAGGCGCCCACATCTACGCGGAGATCGCCGGCTACGCCACGCGCTCCAACGCGTACCACATGACCGGACTGCGCCCCGACGGCGCGGAGATGGCCGAGGCGATCCGCGTGGCGCTGGACGAGGCGCGGATGAACGGCGACGAGATCGACTACATCAACGCCCACGGCTCCGGCACCAAGCAGAACGACCGCCACGAGACGGCGGCGGTCAAGCGGATCCTCGGTGACCACGCCTACCGGACGCCGATGAGCTCCATCAAGTCGATGGTGGGGCACTCGCTCGGCGCGATCGGCTCCATCGAGATCGCCGCGTCCGCGCTCGCCATGGAGTACAACGTCGTACCGCCCACGGCCAACCTGCACACGCCCGACCCCGAGTGCGACCTGGACTACGTCCCGTTGACCGCCCGCGACCGCAAGACCGACGCGGTCCTCTCGGTCGGCAGCGGCTTCGGTGGATTCCAGAGTGCCGTGGTGCTCGCCCGTCCCGAGAGGAAGCTCGCATGA	MEVLAPGGIGTKNFWSLLSEGRTATRGITFFDPTPFRSRVAAEIDFDPYEHGLSPQEVRRMDRAGQFAVVASRGAVADSGLELAGLDPYRVGVTVGSAVGATMGLDEEYRVVSDGGRLDLVDHQYAAPHLYNHLVPSSFAAEVAWAVGAEGPSTVVSTGCTSGIDSVGYAVELIREGSADVMIAGSSDAPISPITMACFDAIKATTNRYDEPETASRPFDNSRNGFVLGEGTAFFVLEELESAVKRGAHIYAEIAGYATRSNAYHMTGLRPDGAEMAEAIRVALDEARMNGDEIDYINAHGSGTKQNDRHETAAVKRILGDHAYRTPMSSIKSMVGHSLGAIGSIEIAASALAMEYNVVPPTANLHTPDPECDLDYVPLTARDRKTDAVLSVGSGFGGFQSAVVLARPERKLA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	99.28	gnl|BL_ORD_ID|1968|hsp_num:0	1943			306	1245	isoniazid
